Matrix metalloproteinase 9 exerts antiviral activity against respiratory syncytial virus

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Dabo, Abdoulaye J ^a   Cummins, Neville ^a   Eden, Edward ^a   Geraghty, Patrick ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; RANTES; STEM CELL FACTOR; CYTOKINE; MMP9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IN VITRO STUDY; IN VIVO STUDY; LUNG LAVAGE; MMP9 GENE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT ALLERGY; SIGNAL TRANSDUCTION; VIRAL CLEARANCE; VIRUS IMMUNITY; VIRUS INFECTIVITY; VIRUS REPLICATION; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; CELL CULTURE; CHEMICALLY INDUCED; DISEASE MODEL; ENZYMOLOGY; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOGENICITY; PHYSIOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; VIROLOGY;

ANIMALS; APOPTOSIS; BRONCHIAL HYPERREACTIVITY; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 84942410251     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135970     Document Type: Article

References (63)

1. Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML. Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. Physiology. 2013; 28(6):391-403. doi: 10.1152/physiol.00029.2013 PMID: 24186934; PubMed Central PMCID: PMC3858212.
2. Foronjy R, Nkyimbeng T, Wallace A, Thankachen J, Okada Y, Lemaitre V, et al. Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin. American journal of physiology Lung cellular and molecular physiology. 2008; 294(6): L1149-57. doi: 10.1152/ajplung.00481.2007 PMID: 18408070.
3. Ventura I, Vega A, Chacon P, Chamorro C, Aroca R, Gomez E, et al. Neutrophils from allergic asthmatic patients produce and release metalloproteinase-9 upon direct exposure to allergens. Allergy. 2014; 69(7):898-905. doi: 10.1111/all.12414 PMID: 24773508.
4. Lee YH, Lai CL, Hsieh SH, Shieh CC, Huang LM, Wu-Hsieh BA. Influenza A virus induction of oxidative stress and MMP-9 is associated with severe lung pathology in a mouse model. Virus research. 2013; 178(2):411-22. doi: 10.1016/j.virusres.2013.09.011 PMID: 24055463.
5. Ng HH, Narasaraju T, Phoon MC, Sim MK, Seet JE, Chow VT. Doxycycline treatment attenuates acute lung injury in mice infected with virulent influenza H3N2 virus: involvement of matrix metalloproteinases. Experimental and molecular pathology. 2012; 92(3):287-95. doi: 10.1016/j.yexmp.2012.03.003 PMID: 22421441.
6. Lemjabbar H, Gosset P, Lechapt-Zalcman E, Franco-Montoya ML, Wallaert B, Harf A, et al. Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment. American journal of respiratory cell and molecular biology. 1999; 20(5):903-13. doi: 10.1165/ajrcmb.20.5.3260 PMID: 10226060.
7. Khokha R, Murthy A, Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nature reviews Immunology. 2013; 13(9):649-65. doi: 10.1038/nri3499 PMID: 23969736.
8. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. The Journal of biological chemistry. 2001; 276(47):43503-8. doi: 10.1074/jbc.M107736200 PMID: 11571304.
9. Van Den Steen PE, Wuyts A, Husson SJ, Proost P, Van Damme J, Opdenakker G. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. European journal of biochemistry / FEBS. 2003; 270(18):3739-49. PMID: 12950257.
10. Bradley LM, Douglass MF, Chatterjee D, Akira S, Baaten BJ. Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling. PLoS pathogens. 2012; 8(4):e1002641. doi: 10.1371/journal.ppat.1002641 PMID: 22496659; PubMed Central PMCID: PMC3320598.
11. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005; 352(17):1749-59. Epub 2005/04/29. doi: 352/17/1749 [pii] doi: 10.1056/NEJMoa043951 PMID: 15858184.
12. Kong MY, Clancy JP, Peng N, Li Y, Szul TJ, Xu X, et al. Pulmonary matrix metalloproteinase-9 activity in mechanically ventilated children with respiratory syncytial virus. The European respiratory journal. 2014; 43(4):1086-96. doi: 10.1183/09031936.00105613 PMID: 24311764; PubMed Central PMCID: PMC4059407.
13. Foronjy RF, Taggart CC, Dabo AJ, Weldon S, Cummins N, Geraghty P. Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors. Mucosal immunology. 2015; 8(1):161-75. doi: 10.1038/mi.2014.54 PMID: 25005357; PubMed Central PMCID: PMC4268269.
14. Marchant DJ, Bellac CL, Moraes TJ, Wadsworth SJ, Dufour A, Butler GS, et al. A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity. Nature medicine. 2014; 20(5):493-502. doi: 10.1038/nm.3508 PMID: 24784232.
15. Long X, Li S, Xie J, Li W, Zang N, Ren L, et al. MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-gamma-independent airway inflammation and AHR post RSV infection in nude mice. Respiratory research. 2015; 16:11. doi: 10.1186/s12931-015-0176-8 PMID: 25652021; PubMed Central PMCID: PMC4332892.
16. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol. 2002; 76(11):5654-66. Epub 2002/05/07. PMID: 11991994; PubMed Central PMCID: PMC137037.
17. McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL. Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Archives of disease in childhood. 2003; 88(10):922-6. PMID: 14500316; PubMed Central PMCID: PMC1719332.
18. Yeo SJ, Yun YJ, Lyu MA, Woo SY, Woo ER, Kim SJ, et al. Respiratory syncytial virus infection induces matrix metalloproteinase-9 expression in epithelial cells. Arch Virol. 2002; 147(2):229-42. Epub 2002/03/14. PMID: 11890521.
19. Foronjy RF, Dabo AJ, Taggart CC, Weldon S, Geraghty P. Respiratory syncytial virus infections enhance cigarette smoke induced COPD in mice. PloS one. 2014; 9(2):e90567. doi: 10.1371/journal.pone.0090567 PMID: 24587397; PubMed Central PMCID: PMC3938768.
20. Hsia CCW, Hyde D.M., Ochs M., Weibel E.R. and on behalf of the ATS/ERS Joint Task Force on the Quantitative Assessment of Lung Structure. An Official Research Policy Statement of the American Thoracic Society/European Respiratory Society: Standards for Quantitative Assessment of Lung Structure. Am J Respir Crit Care Med. 2010; 181(4):394-418. doi: 10.1164/rccm.200809-1522ST PMID: 20130146
21. Foronjy RF, Dabo AJ, Cummins N, Geraghty P. Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection. BMC immunology. 2014; 15(1):41. doi: 10.1186/s12865-014-0041-4 PMID: 25277705; PubMed Central PMCID: PMC4189665.
22. Geraghty P, Hardigan A, Foronjy RF. Cigarette smoke activates the proto-oncogene c-src to promote airway inflammation and lung tissue destruction. American journal of respiratory cell and molecular biology. 2014; 50(3):559-70. doi: 10.1165/rcmb.2013-0258OC PMID: 24111605; PubMed Central PMCID: PMC4068937.
23. Geraghty P, Hardigan AA, Wallace AM, Mirochnitchenko O, Thankachen J, Arellanos L, et al. The glutathione peroxidase 1-protein tyrosine phosphatase 1B-protein phosphatase 2A axis. A key determinant of airway inflammation and alveolar destruction. American journal of respiratory cell and molecular biology. 2013; 49(5):721-30. doi: 10.1165/rcmb.2013-0026OC PMID: 23590304; PubMed Central PMCID: PMC3931101.
24. Reed LJM H. A simple method of estimating fifty per cent endpoints. American Journal of Hygiene. 1938; 27:493-7.
25. Oshita Y, Koga T, Kamimura T, Matsuo K, Rikimaru T, Aizawa H. Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma. Thorax. 2003; 58(9):757-60. PMID: 12947131; PubMed Central PMCID: PMC1746799.
26. Mehra D, Sternberg DI, Jia Y, Canfield S, Lemaitre V, Nkyimbeng T, et al. Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma. American journal of physiology Lung cellular and molecular physiology. 2010; 298(2):L189-96. doi: 10.1152/ajplung.00042.2009 PMID: 19940022; PubMed Central PMCID: PMC2822563.
27. McMillan SJ, Kearley J, Campbell JD, Zhu XW, Larbi KY, Shipley JM, et al. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. Journal of immunology. 2004; 172(4):2586-94. PMID: 14764732.
28. Kinyanjui MW, Shan J, Nakada EM, Qureshi ST, Fixman ED. Dose-dependent effects of IL-17 on IL- 13-induced airway inflammatory responses and airway hyperresponsiveness. Journal of immunology. 2013; 190(8):3859-68. doi: 10.4049/jimmunol.1200506 PMID: 23509346.
29. Ringshausen I, Dechow T, Schneller F, Weick K, Oelsner M, Peschel C, et al. Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells. Leukemia. 2004; 18(12):1964-70. doi: 10.1038/sj.leu.2403544 PMID: 15483673.
30. Balamayooran G, Batra S, Theivanthiran B, Cai S, Pacher P, Jeyaseelan S. Intrapulmonary G-CSF rescues neutrophil recruitment to the lung and neutrophil release to blood in Gram-negative bacterial infection in MCP-1-/- mice. Journal of immunology. 2012; 189(12):5849-59. doi: 10.4049/jimmunol.1200585 PMID: 23129755; PubMed Central PMCID: PMC3518636.
31. Pan ZZ, Parkyn L, Ray A, Ray P. Inducible lung-specific expression of RANTES: preferential recruitment of neutrophils. American journal of physiology Lung cellular and molecular physiology. 2000; 279 (4):L658-66. PMID: 11000125.
32. Hol J, Wilhelmsen L, Haraldsen G. The murine IL-8 homologues KC, MIP-2, and LIX are found in endothelial cytoplasmic granules but not in Weibel-Palade bodies. Journal of leukocyte biology. 2010; 87 (3):501-8. doi: 10.1189/jlb.0809532 PMID: 20007247.
33. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Experimental lung research. 1991; 17(1):17-23. PMID: 2013270.
34. Li W, Shen HH. Effect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice. Chin Med J (Engl). 2007; 120(1):5-11. Epub 2007/01/27. PMID: 17254480.
35. Chakrabarti S, Zee JM, Patel KD. Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release. Journal of leukocyte biology. 2006; 79(1):214-22. doi: 10.1189/jlb.0605353 PMID: 16275891.
36. Borregaard N, Sehested M, Nielsen BS, Sengelov H, Kjeldsen L. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood. 1995; 85(3):812-7. PMID: 7833481.
37. Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. American journal of respiratory cell and molecular biology. 2003; 28(1):12-24. doi: 10.1165/rcmb.2002-0166TR PMID: 12495928.
38. Kanbe N, Tanaka A, Kanbe M, Itakura A, Kurosawa M, Matsuda H. Human mast cells produce matrix metalloproteinase 9. European journal of immunology. 1999; 29(8):2645-9. doi: 10.1002/(SICI)1521-4141(199908)29:08<2645::AID-IMMU2645>3.0.CO;2-1 PMID: 10458779.
39. Lepidi S, Kenagy RD, Raines EW, Chiu ES, Chait A, Ross R, et al. MMP9 production by human monocyte-derived macrophages is decreased on polymerized type I collagen. Journal of vascular surgery. 2001; 34(6):1111-8. doi: 10.1067/mva.2001.119401 PMID: 11743569.
40. Reeves EP, Lu H, Jacobs HL, Messina CG, Bolsover S, Gabella G, et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature. 2002; 416(6878):291-7. Epub 2002/03/22. doi: 10.1038/416291a 416291a [pii]. PMID: 11907569.
41. Yasui K, Baba A, Iwasaki Y, Kubo T, Aoyama K, Mori T, et al. Neutrophil-mediated inflammation in respiratory syncytial viral bronchiolitis. Pediatrics international: official journal of the Japan Pediatric Society. 2005; 47(2):190-5. doi: 10.1111/j.1442-200x.2005.02039.x PMID: 15771699.
42. Cataldo DD, Tournoy KG, Vermaelen K, Munaut C, Foidart JM, Louis R, et al. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. The American journal of pathology. 2002; 161(2):491-8. doi: 10.1016/S0002-9440(10)64205-8 PMID: 12163374; PubMed Central PMCID: PMC1850735.
43. Page K, Ledford JR, Zhou P, Wills-Karp M. A TLR2 agonist in German cockroach frass activates MMP-9 release and is protective against allergic inflammation in mice. Journal of immunology. 2009; 183 (5):3400-8. doi: 10.4049/jimmunol.0900838 PMID: 19667087; PubMed Central PMCID: PMC2749560.
44. McGovern TK, Goldberger M, Allard B, Farahnak S, Hamamoto Y, O'Sullivan M, et al. Neutrophils mediate airway hyperresponsiveness after chlorine-induced airway injury in the mouse. American journal of respiratory cell and molecular biology. 2015; 52(4):513-22. doi: 10.1165/rcmb.2013-0430OC PMID: 25192041.
45. Leigh R, Ellis R, Wattie J, Donaldson DD, Inman MD. Is interleukin-13 critical in maintaining airway hyperresponsiveness in allergen-challenged mice? American journal of respiratory and critical care medicine. 2004; 170(8):851-6. doi: 10.1164/rccm.200311-1488OC PMID: 15242841.
46. Castilow EM, Meyerholz DK, Varga SM. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease. Journal of immunology. 2008; 180(4):2376-84. PMID: 18250447.
47. Tester AM, Cox JH, Connor AR, Starr AE, Dean RA, Puente XS, et al. LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PloS one. 2007; 2(3):e312. doi: 10.1371/journal.pone.0000312 PMID: 17375198; PubMed Central PMCID: PMC1819564.
48. Ichihara M, Hotta T, Asano H, Inoue C, Murate T, Kobayashi M, et al. Effects of stem cell factor (SCF) on human marrow neutrophil, neutrophil/macrophage mixed, macrophage and eosinophil progenitor cell growth. International journal of hematology. 1994; 59(2):81-9. PMID: 7517201.
49. Lin M, Jackson P, Tester AM, Diaconu E, Overall CM, Blalock JE, et al. Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro. The American journal of pathology. 2008; 173(1):144-53. doi: 10.2353/ajpath.2008.080081 PMID: 18556780; PubMed Central PMCID: PMC2438292.
50. Malik M, Bakshi CS, McCabe K, Catlett SV, Shah A, Singh R, et al. Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis. Journal of immunology. 2007; 178(2):1013-20. PMID: 17202364.
51. Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, Galin FS, et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nature medicine. 2006; 12(3):317-23. doi: 10.1038/nm1361 PMID: 16474398.
52. Overbeek SA, Henricks PA, Srienc AI, Koelink PJ, de Kruijf P, Lim HD, et al. N-acetylated Proline-Glycine-Proline induced G-protein dependent chemotaxis of neutrophils is independent of CXCL8 release. European journal of pharmacology. 2011; 668(3):428-34. doi: 10.1016/j.ejphar.2011.03.022 PMID: 21458443; PubMed Central PMCID: PMC3761398.
53. Louhelainen N, Stark H, Mazur W, Rytila P, Djukanovic R, Kinnula VL. Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study. BMC pulmonary medicine. 2010; 10:13. doi: 10.1186/1471-2466-10-13 PMID: 20226090; PubMed Central PMCID: PMC2841651.
54. Luplertlop N, Misse D. MMP cellular responses to dengue virus infection-induced vascular leakage. Japanese journal of infectious diseases. 2008; 61(4):298-301. PMID: 18653973.
55. Fridman R, Toth M, Chvyrkova I, Meroueh SO, Mobashery S. Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer metastasis reviews. 2003; 22(2-3):153-66. PMID: 12784994.
56. Ellerbroek SM, Halbleib JM, Benavidez M, Warmka JK, Wattenberg EV, Stack MS, et al. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. Cancer research. 2001; 61(5):1855-61. PMID: 11280738.
57. Olson MW, Toth M, Gervasi DC, Sado Y, Ninomiya Y, Fridman R. High affinity binding of latent matrix metalloproteinase-9 to the alpha2(IV) chain of collagen IV. The Journal of biological chemistry. 1998; 273(17):10672-81. PMID: 9553130.
58. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes & development. 1999; 13(1):35-48. PMID: 9887098; PubMed Central PMCID: PMC316376.
59. McCurdy LH, Graham BS. Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation. Journal of virology. 2003; 77(3):1747-56. PMID: 12525608; PubMed Central PMCID: PMC140864.
60. Khan AI, Kerfoot SM, Heit B, Liu L, Andonegui G, Ruffell B, et al. Role of CD44 and hyaluronan in neutrophil recruitment. Journal of immunology. 2004; 173(12):7594-601. PMID: 15585887.
61. Julovi SM, Ito H, Nishitani K, Jackson CJ, Nakamura T. Hyaluronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and P38. Journal of orthopaedic research: official publication of the Orthopaedic Research Society. 2011; 29(2):258-64. doi: 10.1002/jor.21216 PMID: 20706991.
62. Marchant D, Singhera GK, Utokaparch S, Hackett TL, Boyd JH, Luo Z, et al. Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism. Journal of virology. 2010; 84(21):11359-73. doi: 10.1128/JVI.00804-10 PMID: 20702616; PubMed Central PMCID: PMC2953195.
63. Fricke J, Koo LY, Brown CR, Collins PL. p38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly. Journal of virology. 2013; 87(3):1333-47. doi: 10.1128/JVI.02263-12 PMID: 23152511; PubMed Central PMCID: PMC3554139.